OSP-rT2544 is glycoconjugate vaccine candidate against salmonella infection
Jan. 12, 2024
Researchers from Indian Council of Medical Research and affiliated organizations presented the discovery and preclinical evaluation of OSP-rT2544, being developed for the treatment of salmonella.